Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
NCT ID: NCT06289699
Last Updated: 2025-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-02-26
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Outcomes After Implementation of COntinuous Vital Sign Monitoring On the General Ward.
NCT04189653
Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?
NCT06361862
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
NCT05536206
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
NCT05378139
Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways
NCT05181111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Monitoring devices used in this study will be validated FDA or/and CE approved devices used within their original purpose. Centers can choose to use Sotera Visimobile or Isansys Lifeguard with accompanying sensors. These devices will be used together with the CE approved WARD web and mobile application.
Study sites include: St. Olav Hospital Trondheim, Royal Liverpool University Hospital, University Medical Centre Hamburg-Eppendorf,University Medical Centre Groningen, The Netherlands and the Cleveland Clinic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Expected stay in the hospital ≥2 days
* Admitted for surgery with expected duration of surgery \>2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff
* RR \> 21 breaths pr minute
* RR \< 11 breaths pr minute
* Pulse (P) \> 91 beats pr minute
* Pulse (P) \< 50 beats pr minute
* SpO2 \< 94 % without oxygen supplementation
* Systolic BP \< 110 mmHg
* Systolic BP \> 220 mmHg
Exclusion Criteria
* Allergy to plaster or silicone.
* Pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
* Inability to give informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Christian S. Meyhoff
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian S. Meyhoff
Professor, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian S Meyhoff, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Eske K Aasvang, MD, DMSci
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Copenhagen University, Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Cleveland Clinic Foundation, General Anesthesiology
Cleveland, Ohio, United States
Universitätsklinikum Hamburg-Eppendorf (UKE), Zentrum für Anästhesiologie und Intensivmedizin, Klinik und Poliklinik für Anästhesiologie
Hamburg, , Germany
University Medical Center Groningen, Department of Anesthesiology
Groningen, , Netherlands
St. Olavs Hospital HF, Klinikk for anestesi og intensivmedisin
Trondheim, , Norway
Liverpool University Hospitals NHS Foundation Trust
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Daniel Sessler, MD
Role: primary
Marjolein Haveman, TP
Role: primary
Ingeborg Welters, Dr. Med.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WARD-CSS international 1251
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.